Fukui

Running trials

• Active, not recruiting

  TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

  NCT05729711· Source

• Active, not recruiting

  SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)

  NCT05141201· Source

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

  NCT05677308· Source

• Completed

  Forxiga CKD Japan Post-Marketing Surveillance (PMS)

  NCT05306210· Source

• Completed

  Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

  NCT04872621· Source

• Completed

  Forxiga HF General Drug Use-Results Study

  NCT04865406· Source